Late Endovascular Revascularization in Acute Ischemic Stroke Based on Clinical-Diffusion Mismatch

References

1. ↵
   Tissue plasminogen activator for acute ischemic stroke: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581–87

   CrossRefPubMedWeb of Science
2. ↵
   Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study—a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

   CrossRefPubMedWeb of Science
3. ↵
   Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432–38. Epub 2005 Jun 16

   Abstract/FREE Full Text
4. Gobin YP, Starkman S, Duckwiler GR, et al. Merci 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004;35:2848–54. Epub 2004 Oct 28

   Abstract/FREE Full Text
5. ↵
   Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205–12. Epub 2008 Feb 28

   Abstract/FREE Full Text
6. ↵
   Clark WM, Albers GW, Madden KP, et al. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study—thromblytic therapy in acute ischemic stroke study investigators. Stroke 2000;31:811–16

   Abstract/FREE Full Text
7. ↵
   Davis DP, Robertson T, Imbesi SG. Diffusion-weighted magnetic resonance imaging versus computed tomography in the diagnosis of acute ischemic stroke. J Emerg Med 2006;31:269–77

   CrossRefPubMedWeb of Science
8. ↵
   Lansberg MG, Albers GW, Beaulieu C, et al. Comparison of diffusion-weighted MRI and CT in acute stroke. Neurology 2000;54:1557–61

   Abstract/FREE Full Text
9. ↵
   Chalela JA, Kidwell CS, Nentwich LM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007;369:293–98

   CrossRefPubMedWeb of Science
10. ↵
    Davalos A, Blanco M, Pedraza S, et al. The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology 2004;62:2187–92

    Abstract/FREE Full Text
11. ↵
    Prosser J, Butcher K, Allport L, et al. Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 2005;36:1700–04

    Abstract/FREE Full Text
12. ↵
    Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy: ASPECTS Study Group Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670–74

    CrossRefPubMedWeb of Science
13. ↵
    Tei H, Uchiyama S, Usui T. Clinical-diffusion mismatch defined by NIHSS and ASPECTS in non-lacunar anterior circulation infarction. J Neurol 2007;254:340–46

    CrossRefPubMed
14. ↵
    Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase—clinical findings through hospital discharge. Circulation 1987;76:142–54

    Abstract/FREE Full Text
15. ↵
    Chaturvedi S, Adams HP Jr, Woolson RF. Circadian variation in ischemic stroke subtypes. Stroke 1999;30:1792–95

    Abstract/FREE Full Text
16. Lago A, Geffner D, Tembl J, et al. Circadian variation in acute ischemic stroke: a hospital-based study. Stroke 1998;29:1873–75

    Abstract/FREE Full Text
17. ↵
    Elliot WJ. Cyclic and circadian variations in cardiovascular events. Am J Hypertens 2001;14:291S–95S

    CrossRefPubMed
18. ↵
    Bang OY, Saver JL, Buck BH, et al. Impact of collateral flow on tissue fate in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2008;79:625–29

    Abstract/FREE Full Text
19. ↵
    Furlan AJ, Eyding D, Albers GW, et al. Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227–31

    Abstract/FREE Full Text
20. ↵
    Lee K, Han SW, Kim SH, et al. Low efficacy of intravenous TPA in acute cerebral infarction involving the large cerebral arteries. Paper presented at: International Stroke Conference; February 16–18,2006; Kissimmee, Fla
21. Christou I, Burgin WS, Alexandrov AV, et al. Arterial status after intravenous TPA therapy for ischaemic stroke: a need for further interventions. Int Angiol 2001;20:208–13

    PubMedWeb of Science
22. ↵
    Linfante I, Llinas RH, Selim M, et al. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 2002;33:2066–71

    Abstract/FREE Full Text